Consolidated Statements of Operations - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Revenues:
Premiums	$ 99,192	$ 85,330	$ 76,132
Net investment income	1,153	838	1,199
Total revenues	357,776	322,467	292,111
Operating costs:
Cost of products sold	217,098	196,892	175,803
Health care costs	86,247	71,073	64,188
Restructuring charges	507	0	0
Opioid litigation charges	0	5,803	0
Loss on assets held for sale	349	2,533	0
Store impairments	0	0	1,358
Goodwill impairment	0	0	431
Operating expenses	39,832	38,212	37,021
Total operating costs	344,033	314,513	278,801
Operating income	13,743	7,954	13,310
Interest expense	2,658	2,287	2,503
Loss on early extinguishment of debt	0	0	452
Other income	(88)	(169)	(182)
Income before income tax provision	11,173	5,836	10,537
Income tax provision	2,805	1,509	2,548
Net income	8,368	4,327	7,989
Net (income) loss attributable to noncontrolling interests	(24)	(16)	12
Net income attributable to CVS Health	$ 8,344	$ 4,311	$ 8,001
Net income per share attributable to CVS Health:
Basic (in dollars per share)	$ 6.49	$ 3.29	$ 6.07
Diluted (in dollars per share)	$ 6.47	$ 3.26	$ 6.02
Weighted average shares outstanding:
Basic (in shares)	1,285	1,312	1,319
Diluted (in shares)	1,290	1,323	1,329
Dividends declared per share (in dollars per share)	$ 2.42	$ 2.20	$ 2.00
Cost, Product and Service [Extensible List]	Products	Products	Products
Products
Revenues:
Revenues	$ 245,138	$ 226,616	$ 203,738
Services
Revenues:
Revenues	$ 12,293	$ 9,683	$ 11,042